Tracon Pharmaceuticals Stock Cash Flow From Operations
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess TRACON Pharmaceuticals' long-term financial health and intrinsic value.
TRACON |
TRACON Pharmaceuticals OTC Stock Cash Flow From Operations Analysis
TRACON Pharmaceuticals' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current TRACON Pharmaceuticals Cash Flow From Operations | 3.68 M |
Most of TRACON Pharmaceuticals' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TRACON Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, TRACON Pharmaceuticals has 3.68 M in Cash Flow From Operations. This is 99.3% lower than that of the Biotechnology sector and 94.12% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 99.62% higher than that of the company.
TRACON Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TRACON Pharmaceuticals' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of TRACON Pharmaceuticals could also be used in its relative valuation, which is a method of valuing TRACON Pharmaceuticals by comparing valuation metrics of similar companies.TRACON Pharmaceuticals is currently under evaluation in cash flow from operations category among its peers.
TRACON Fundamentals
| Return On Equity | -12.77 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | (32.12) % | ||||
| Current Valuation | (2.64 M) | ||||
| Shares Outstanding | 2.68 M | ||||
| Shares Owned By Insiders | 2.20 % | ||||
| Shares Owned By Institutions | 11.42 % | ||||
| Number Of Shares Shorted | 166.13 K | ||||
| Price To Earning | (1.51) X | ||||
| Price To Book | 11.83 X | ||||
| Price To Sales | 0.45 X | ||||
| Revenue | 12.04 M | ||||
| Gross Profit | (13.89 M) | ||||
| EBITDA | (6.88 M) | ||||
| Net Income | (3.59 M) | ||||
| Cash And Equivalents | 13.58 M | ||||
| Cash Per Share | 0.63 X | ||||
| Total Debt | 968 K | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 1.17 X | ||||
| Book Value Per Share | (0.66) X | ||||
| Cash Flow From Operations | 3.68 M | ||||
| Short Ratio | 0.95 X | ||||
| Earnings Per Share | 106.40 X | ||||
| Target Price | 30.5 | ||||
| Number Of Employees | 17 | ||||
| Beta | 1.24 | ||||
| Market Capitalization | 3.83 M | ||||
| Total Asset | 10.11 M | ||||
| Retained Earnings | (240.5 M) | ||||
| Working Capital | (1.09 M) | ||||
| Current Asset | 53.31 M | ||||
| Current Liabilities | 14.18 M | ||||
| Net Asset | 10.11 M |
Pair Trading with TRACON Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TRACON Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TRACON Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in TRACON OTC Stock
If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |